Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: 3675 Market Street
City: Philadelphia
State: PA
Zip: 19104
Country: US
Spirovant is focused on changing the course of cystic fibrosis and other pulmonary diseases. Their gene therapy technologies are designed to overcome the historical barriers that have prevented effective genetic treatments for cystic fibrosis.
Contact Phone:
+12672448206
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Grant | 1 | $4.5M |
Cystic Fibrosis Foundation Cystic Fibrosis Foundation |
6/2017 | Grant | 1 | $225k |
Small Business Innovation Research Small Business Innovation Research |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|